Systemic Lupus Erythematosus |
Sle |
Clinical Trial: Study of LymphoStat-B in Subjects with Systemic Lupus Erythematosus (SLE)
This study is no longer recruiting patients.
Purpose
The purpose of this study is to evaluate the safety and efficacy of 3 different doses of LymphoStat-B, administered in addition to standard therapy, in subjects with active SLE disease.
| Condition | Treatment or Intervention | Phase |
|---|---|---|
| Lupus Erythematosus, Systemic | Drug: belimumab (LymphoStat-B) | Phase II |
MedlinePlus related topics: Lupus
Study Type: Interventional
Study Design: Treatment, Randomized, Double-Blind, Placebo Control, Parallel Assignment, Safety/Efficacy Study
Official Title: A Phase 2, Multi-Center, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Safety, Tolerability, and Efficacy of LymphoStat-B™ Antibody (Monoclonal Anti-BLyS Antibody) in Subjects with Systemic Lupus Erythematosus (SLE)
Eligibility
Ages Eligible for Study: 18 Years and above, Genders Eligible for Study: Both
Criteria
Primary Inclusion Criteria
- Clinical diagnosis of SLE
- “Active” SLE disease
- On a stable SLE treatment regimen
- History of measurable autoantibodies
Primary Exclusion Criteria
- Received a non-FDA approved investigational agent within last 28 days
- Cyclosporin, IVIG or plasmapheresis within last 90 days
- Active lupus nephritis requiring hemodialysis, cyclophosphamide (Cytoxan™), or high-dose prednisone (> 100 mg/day) within last 90 days
- Active CNS lupus requiring therapeutic intervention within last 60 days
- History of renal transplant
- History of chronic infection that has been active within last 6 months, herpes zoster within last 90 days or any infection requiring hospitalization or intravenous medication within last 60 days
- History of hypogammaglobulinemia or IgA deficiency
- HIV, Hepatitis B, Hepatitis C
Location Information
Alabama
University of Alabama at Birmingham, Birmingham, Alabama, 35294-0006, United States
Arizona
Arizona Arthritis Research, Paradise Valley, Arizona, 85253, United States
University of Arizona, Tucson, Arizona, 85724, United States
California
Boling Clinical Trials, Rancho Cucamonga, California, 91730, United States
Stanford University School of Medicine, Palo Alto, California, 94304, United States
Arthritis Care Center, Inc., San Jose, California, 95126-1650, United States
Scripps Clinic, LaJolla, California, 92037, United States
University of Southern California, Los Angeles, California, 90033, United States
UCDMC, Sacramento, California, 95817-1418, United States
Cedars-Sinai Medical Center, Los Angeles, California, 90048, United States
Colorado
Arthritis Associates & Osteoporosis Center Of Colorado Springs, Colorado Springs, Colorado, 80910, United States
District of Columbia
Washington Hospital Center, Washington, District of Columbia, 20010, United States
Florida
Tampa Medical Group, P.A., Tampa, Florida, 33614, United States
Arthritis and Rheumatic Disease Specialties, Aventura, Florida, 33180, United States
Rheumatology Associates of Central Florida, Orlando, Florida, 32806, United States
Georgia
Emory University, Atlanta, Georgia, 30303, United States
Idaho
Radiant Research Boise, Boise, Idaho, 83704, United States
Institute of Arthritis and Research, Idaho Falls, Idaho, 83404, United States
Illinois
Northwestern University Medical School, Chicago, Illinois, 60611, United States
Rheumatology Associates, Chicago, Illinois, 60612, United States
Indiana
Medical Specialists, Munster, Indiana, 46321, United States
Kentucky
Kentuckiana Center for Better Bone and Joint Health, Louisville, Kentucky, 40202, United States
Louisiana
Ochsner Clinic Foundation, Baton Rouge, Louisiana, 70809, United States
Ochsner Clinic Foundation, New Orleans, Louisiana, 70121, United States
Maryland
Center for Rheumatology and Bone Research, Wheaton, Maryland, 20902, United States
The Osteoporosis and Arthritis Clinical Trial Center, Cumberland, Maryland, 21502, United States
Johns Hopkins Hospital, Baltimore, Maryland, 21287, United States
University of Maryland, Baltimore, Maryland, 21201, United States
Massachusetts
Tufts--New England Medical Center, Boston, Massachusetts, 02111, United States
Michigan
The University of Michigan Health System, Ann Arbor, Michigan, 48109-0358, United States
Missouri
Washington University in St. Louis, St. Louis, Missouri, 63110, United States
Nebraska
Arthritis Center of Nebraska, Lincoln, Nebraska, 68506, United States
New Hampshire
Strafford Medical Associates, P.A., Dover, New Hampshire, 03820, United States
Arthritis and Osteoporosis Center, Concord, New Hampshire, 03301, United States
New York
SUNY-Downstate Medical Center, Brooklyn, New York, 11203, United States
Jacobi Medical Center, Bronx, New York, 10461, United States
Aair Research, Rochester, New York, 14618, United States
North Shore University Hospital, Manhasset, New York, 11030, United States
The Center for Rheumatology, Albany, New York, 12206, United States
North Carolina
University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, 27599-7280, United States
Arthritis Clinic and Carolina Bone and Joint, Charlotte, North Carolina, 28210, United States
Wake Forest University School of Medicine, Winston Salem, North Carolina, 27157, United States
Ohio
Stat Research Inc., Dayton, Ohio, 45402, United States
Oklahoma
Oklahoma Center For Arthritis Therapy & Research, Tulsa, Oklahoma, 74114, United States
Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, 73104, United States
Bone and Joint Hospital, Oklahoma City, Oklahoma, 73103, United States
Pennsylvania
Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, 19107, United States
University of Pittsburgh School of Medicine & ASPH, Pittsburgh, Pennsylvania, 15261, United States
Rheumatic Disease Associates, Willow Grove, Pennsylvania, 19090, United States
Texas
UT Southwestern Medical Center at Dallas, Dallas, Texas, 75390-8884, United States
Research Associates of North Texas, Dallas, Texas, 75246, United States
Texas Research Center, Sugar Land, Texas, 77479, United States
Utah
Arthritis and Rheumatic Disease Clinic, Ogden, Utah, 84044, United States
Physicians Research Options, LC, Sandy, Utah, 84070, United States
Virginia
Arthritis Clinic of Northern Virginia, P.C., Arlington, Virginia, 22205, United States
Washington
Edmonds Rheumatology Associates, Edmonds, Washington, 98026-8047, United States
Arthritis Northwest Rheumatology, Spokane, Washington, 99204, United States
Wisconsin
The Medical College of Wisconsin , Inc, Milwaukee, Wisconsin, 53226, United States
Gundersen Clinic, Ltd., La Crosse, Wisconsin, 54610, United States
Marshfield Medical Research Foundation, Wausau, Wisconsin, 54401, United States
Canada, Ontario
Toronto Western Hospital, Toronto, Ontario, M5T 2S8, Canada
Canada, Quebec
McGill University Health Center, Montreal, Quebec, H3G 1A4, Canada
More Information
Record last reviewed: August 2004
Last Updated: October 13, 2004
Record first received: October 24, 2003
ClinicalTrials.gov Identifier: NCT00071487
Health Authority: United States: Food and Drug Administration
ClinicalTrials.gov processed this record on 2005-04-08
Source: ClinicalTrials.gov
Cache Date: April 9, 2005
Resources
- Autoimmune Diseases (Cleveland Clinic)
- Lupus (HealthWorld)

Not Signed In -

